Chronic Spontaneous Urticaria: Expert Perspectives on the Advances in the Therapeutic Landscape
Released On
December 15, 2022
Expires On
December 14, 2023
Media Type
Internet
Completion Time
60 minutes
Specialty
Allergy & Immunology, Dermatology
Topic(s)
Allergies
Scroll to the Bottom of this Information to Begin this Course
This continuing medical education activity is provided by Vindico Medical Education.
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
The intended audience for this activity is allergists, dermatologists, advanced practice providers, and other health care professionals involved in the management of patients with chronic spontaneous urticaria.
Program Overview
This activity will cover the burden of chronic spontaneous urticaria (CSU) on patient health-related quality of life, the current management guidelines, and the available and emerging treatment options for CSU.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Examine the burden and pathogenesis of chronic spontaneous urticaria (CSU) as well as the significance of biomarkers.
- Outline the latest CSU guideline recommendations by major consensus groups including their benefits and limitations, as well as similarities and differences.
- Review the current and investigational treatment options for the management of CSU.
Faculty
Thomas B. Casale, MD, FACP, FAAAAI, FACAAI
Chief Medical Advisor Food Allergy Research and Education (FARE)
Distinguished Chair, FARE Clinical Network
Professor of Medicine and Pediatrics
Director, Division of Allergy and Immunology Joy McCann Culverhouse Clinical Research Center University of South Florida
Tampa, FL
Laura K. Ferris, MD, PhD
Professor of Dermatology
University of Pittsburgh
Pittsburgh, PA
Kristin Sokol, MD, MPH, MS
Allergist/Immunologist Physician
Schreiber Allergy
Rockville, MD
Accreditation Statement
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.0 hours credit for completing this program.
Disclosures of Conflicts of Interest
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Relationship information is accurate at the time of content development.
Faculty report the following relevant financial relationship(s)
- Thomas B. Casale, MD, FACP, FAAAAI, FACAAI
-
- Consultant: Genentech, GlaxoSmithKline, Novartis, Sanofi-Regeneron
- Speaker Contracted by Ineligible Company: Genentech, GlaxoSmithKline, Sanofi-Regeneron
- Independent Research Contractor: Genentech, Sanofi-Regeneron
- Data Safety Monitoring Board: Novartis
- Laura K. Ferris, MD, PhD
-
- Advisor: DermTech
- Consultant: AbbVie, DermTech, Regeneron
- Independent Research Contractor: Aristea, Dermavant, DermTech, Novartis, Regeneron
Kristin Sokol, MD: No relevant financial relationships to disclose.
Reviewer reports the following relevant financial relationship(s):
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP: No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s): No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity.
To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Contact Information
For CME questions? please contact: CME@VindicoCME.com.